Technical Analysis for HTGM - HTG Molecular Diagnostics, Inc.

Grade Last Price % Change Price Change
grade F 2.39 0.84% 0.02
HTGM closed up 0.84 percent on Monday, March 18, 2019, on approximately normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Down
See historical HTGM trend table...

Date Alert Name Type % Chg
Mar 18 50 DMA Resistance Bearish 0.00%
Mar 18 Doji - Bearish? Reversal 0.00%
Mar 15 50 DMA Resistance Bearish 0.84%
Mar 15 Oversold Stochastic Weakness 0.84%
Mar 14 Wide Bands Range Expansion 6.70%
Mar 14 Down 3 Days in a Row Weakness 6.70%
Mar 14 Down 4 Days in a Row Weakness 6.70%
Mar 14 Down 5 Days in a Row Weakness 6.70%
Mar 14 Lower Bollinger Band Touch Weakness 6.70%
Mar 14 Oversold Stochastic Weakness 6.70%

Older signals for HTGM ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
HTG Molecular Diagnostics, Inc. develops and markets a technology platform that facilitates the routine use of complex molecular profiling. The company's HTG Edge platform consists of instrumentation, consumables, and software analytics that are used in sample profiling applications, including tumor profiling, molecular diagnostic testing, and biomarker development. The HTG Edge platform automates the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. It provides molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology comprising HTG Edge Immuno-oncology Assay, HTG Edge FGFR Expression Assay, HTG Edge DLBCL Cell of Origin Assay, HTG EdgeSeq microRNA Whole-transcriptome Assay, HTG Edge Top Oncogene Assay, and HTG Edge DMPK Assay. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States; and through distributors or sales agents in parts of Europe, India, and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
Medicine Biotechnology Biology Nature Tumor Drug Development Molecular Diagnostics Edge Assay Biomarker Microrna
Is HTGM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.83
52 Week Low 2.03
Average Volume 369,028
200-Day Moving Average 3.2693
50-Day Moving Average 2.4016
20-Day Moving Average 2.547
10-Day Moving Average 2.421
Average True Range 0.2021
ADX 23.91
+DI 18.1728
-DI 20.4329
Chandelier Exit (Long, 3 ATRs ) 2.3037
Chandelier Exit (Short, 3 ATRs ) 2.7263
Upper Bollinger Band 2.9187
Lower Bollinger Band 2.1753
Percent B (%b) 0.29
BandWidth 29.187279
MACD Line -0.0292
MACD Signal Line 0.008
MACD Histogram -0.0372
Fundamentals Value
Market Cap 27.36 Million
Num Shares 11.4 Million
EPS -2.95
Price-to-Earnings (P/E) Ratio -0.81
Price-to-Sales 5.18
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.74
Resistance 3 (R3) 2.75 2.64 2.68
Resistance 2 (R2) 2.64 2.56 2.64 2.66
Resistance 1 (R1) 2.52 2.50 2.51 2.51 2.64
Pivot Point 2.41 2.41 2.41 2.41 2.41
Support 1 (S1) 2.29 2.33 2.28 2.28 2.14
Support 2 (S2) 2.18 2.27 2.18 2.12
Support 3 (S3) 2.06 2.18 2.10
Support 4 (S4) 2.05